Association of NEDA-4 With No Long-term Disability Progression in Multiple Sclerosis and Comparison With NEDA-3: A Systematic Review and Meta-analysis

BACKGROUND AND OBJECTIVES: No evidence of disease activity (NEDA)-4 has been suggested as a treatment target for disease-modifying therapy (DMT) in relapsing-remitting multiple sclerosis (RRMS). However, the ability of NEDA-4 to discriminate long-term outcomes in MS and how its performance compares...

Descripción completa

Detalles Bibliográficos
Autores principales: Rotstein, Dalia, Solomon, Jacqueline M., Sormani, Maria Pia, Montalban, Xavier, Ye, Xiang Y., Dababneh, Dina, Muccilli, Alexandra, Saab, Georges, Shah, Prakesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558627/
https://www.ncbi.nlm.nih.gov/pubmed/36224046
http://dx.doi.org/10.1212/NXI.0000000000200032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558627/
https://www.ncbi.nlm.nih.gov/pubmed/36224046
http://dx.doi.org/10.1212/NXI.0000000000200032

Ejemplares similares